Insights From the 2023 ASCO Annual Meeting

Conference Coverage

Research Shows that Health Care Costs Vary Based on HIC Status in Patients With NSCLC

06/13/2023

Emry Lloyd

In an abstract presented at ASCO 2023, researchers compared real-world data on health care costs for HIC-H and HIC-C patients with NSCLC before and after they received the HIC test.

In an abstract presented at ASCO...

06/13/2023

Journal of Clinical Pathways

Conference Coverage

Improving Oncology Acute Care Event Prediction Through Machine Learning Algorithms

06/08/2023

Hannah Musick

Combining patient-reported outcome measures (PROMs) with electronic health record (EHR) data may improve machine learning algorithms’ ability to predict the risk of acute care events in patients with cancer.

Combining patient-reported...

06/08/2023

First Report Managed Care

Conference Coverage

Significant Number of Solid Tumor Drug Approvals Added Complexity to Existing Regimens

06/08/2023

Maria Asimopoulos

A significant portion of drug approvals for nonhematologic solid cancers in the last 12 years were for indications which added to existing regimens, which could increase costs and exposure to side effects, researchers said.

A significant portion of drug...

06/08/2023

First Report Managed Care

Conference Coverage

Medicaid Expansion Linked to Early Breast Cancer Treatment, Survival Among Young Adult Women

06/02/2023

Hannah Musick

A new study showed Medicaid expansion in the United States was associated with increased receipt of timely, guideline-concordant breast cancer treatment and improved survival for young adult women.

A new study showed Medicaid...

06/02/2023

First Report Managed Care

Conference Coverage

Breast Cancer Data Discrepancies Found Across National Tumor Registries

06/02/2023

Hannah Musick

Researchers at the 2023 ASCO Annual Meeting compared data on breast cancer cases in 3 national databases to identify differences in case coverage.

Researchers at the 2023 ASCO...

06/02/2023

First Report Managed Care

Conference Coverage

FDA Oncology Approvals Commonly Involve Surrogate Endpoints, Analysis Shows

06/02/2023

Maria Asimopoulos

In an updated analysis presented at the 2023 ASCO Annual Meeting, researchers examined the frequency with which surrogate endpoints were used to support oncology approvals from 2006 to 2022.

In an updated analysis presented...

06/02/2023

First Report Managed Care

Conference Coverage

Medicare Telehealth Utilization Rates Lowest in Regions Lacking Access to Specialized Cancer Care

06/02/2023

Maria Asimopoulos

"Advocacy and policy efforts directed towards increasing access to telehealth can ensure equitable and timely access to specialized cancer care in these regions of need," researchers said.

"Advocacy and policy efforts...

06/02/2023

First Report Managed Care

Conference Coverage

Peripheral Myeloid Cells as Effective Prognostic Markers in Patients With NSCLC Treated With Cemiplimab

06/01/2023

Grace Taylor

Researchers evaluated the use of myeloid cells, including monocytes and eosinophilis, as prognostic biomarkers for patients with non-small cell lung cancer (NSCLC) who have been treated with cemiplimab.

Researchers evaluated the use of...

06/01/2023

First Report Managed Care

Conference Coverage

Treating Advanced Melanoma With Fianlimab and Cemiplimab

06/01/2023

Grace Taylor

Researchers at ASCO 2023 presented data on the outcomes of treating patients with advanced melanoma, including patients who previously received adjuvant therapy, with fianlimab and cemiplimab.

Researchers at ASCO 2023...

06/01/2023

First Report Managed Care

Insights From the 2023 ASCO Annual Meeting

Specialties

Events

Year Round Education

HMP Global Products